Endomyocardial biopsy in the diagnosis of cardiac sarcoidosis

2 September 2024 (13:00 - 13:50)

Organised by:

Video

Abstract

Sign in to view the resources

Slides

About the speaker

Ms Henriikka Malkonen

Helsinki University Hospital, Helsinki (Finland)

7 More presentations in this session

Presentation thumbnail

Mildly elevated left ventricular outflow tract gradients are associated with increased short term mortality in inpatients without septal hypertrophy

Doctor S. Khoury (Tel Aviv, IL)

Abstract Slides Video

Presentation thumbnail

Health-related quality of life disparity in cardiac sarcoidosis versus other myocardial diseases

Mrs J. Raak-Tarkiainen (Helsinki, FI)

Abstract Slides Video

Presentation thumbnail

Health-related quality of life and prognosis in cardiac sarcoidosis

Mrs J. Raak-Tarkiainen (Helsinki, FI)

Abstract Slides Video

Presentation thumbnail

Prevalence of transthyretin amyloid cardiomyopathy in patients with left ventricular hypertrophy: the RETTRACE Study

Doctor D. Tsilakis (Athens, GR)

Abstract Slides Video

Presentation thumbnail

The role of 18fluorine-fluorodeoxyglucose positron emission tomography in the diagnosis, follow-up, and regulation of treatment in patients with cardiac sarcoidosis.

Doctor E. Bobbio (Gothenburg, SE)

Abstract Slides Video

Access the full session

Session thumbnail

Left ventricular hypertrophy and hypertrophic cardiomyopathy: new findings

The Event

Event poster

ESC Congress 2024

2 September 2024 13:00 CET

You may be interested in

Congress Presentation

When imaging is not enough: diagnostic performance of endomyocardial biopsy in cardiac amyloidosis

Congress Presentation

The diagnostic value of endomyocardial biopsy in the era of precision medicine: data from over 8,000 patients with comprehensive biopsy diagnostics

Congress Presentation

Role of biopsy

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources